Ranger Investment Management - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 185 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ranger Investment Management ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$15,512,000
-6.6%
468,796
-1.0%
1.06%
-11.9%
Q1 2019$16,600,000
+19.5%
473,751
+13.3%
1.20%
+5.9%
Q4 2018$13,887,000
-54.1%
418,033
-30.4%
1.13%
-43.2%
Q3 2018$30,233,000
+7.7%
600,464
+28.0%
2.00%
+1.7%
Q2 2018$28,066,000
+27.0%
468,933
-2.8%
1.96%
+20.2%
Q1 2018$22,104,000
+1.5%
482,630
-11.7%
1.63%
+2.0%
Q4 2017$21,777,000
-44.9%
546,469
-44.7%
1.60%
-46.1%
Q3 2017$39,554,000
-17.6%
988,840
-11.2%
2.97%
-13.3%
Q2 2017$47,981,000
+3.4%
1,113,255
-24.9%
3.42%
+1.6%
Q1 2017$46,403,000
+27.4%
1,482,535
+2.8%
3.37%
+30.3%
Q4 2016$36,421,000
-1.3%
1,442,404
-3.3%
2.58%
-2.3%
Q3 2016$36,893,000
-21.8%
1,491,835
-35.6%
2.64%
-9.1%
Q2 2016$47,188,000
+28.4%
2,316,562
-3.9%
2.91%
+29.2%
Q1 2016$36,761,000
+37.8%
2,410,586
+21.4%
2.25%
+43.2%
Q4 2015$26,678,000
+21.9%
1,984,978
+27.2%
1.57%
+27.6%
Q3 2015$21,893,000
-8.1%
1,560,453
+11.3%
1.23%
+6.3%
Q2 2015$23,815,000
+1199.9%
1,402,514
+825.8%
1.16%
+1203.4%
Q1 2015$1,832,000
+49.1%
151,500
+2.3%
0.09%
+41.3%
Q4 2014$1,229,000148,1300.06%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders